Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
AP4B1 antisense RNA 1 (AP4B1-AS1) is a long non-coding RNA located on chromosome 1p13.2, overlapping and antisense to the AP4B1 gene[1][4]. It does not code for a protein but is a regulatory RNA transcript implicated in modulating the expression of neighboring genes, particularly AP4B1. AP4B1-AS1 demonstrates tissue-specific gene regulatory activity, notably within lung epithelial cells, where genetic variation at its locus has been associated with type 1 diabetes risk through the modulation of enhancer activity and transcript levels. However, AP4B1-AS1 has not been shown to play roles in other autoimmune disorders (e.g., pemphigus foliaceus) or cancer. No drugs or clinical interventions directly target AP4B1-AS1, and it is not currently considered a conventional therapeutic target such as a receptor, enzyme, or transporter. Its biological function centers on antisense-mediated regulation affecting chromatin structure and gene expression, which may influence disease susceptibility in specific genetic contexts[1][2][4].
Not applicable. AP4B1-AS1 as a non-coding, regulatory RNA is not presently a pharmacological target and thus no mechanism is established for drugs.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on AP4B1 antisense RNA 1 (AP4B1-AS1).